United Services Automobile Association Ultragenyx Pharmaceutical Inc. Transaction History

United Services Automobile Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$42.5 - $63.11 $1.34 Million - $1.99 Million	-31,483 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$54.93 - $74.36 $11,809 - $15,987	215 Added 0.69%	31,483 $2 Million
Q1 2019 May 13, 2019	BUY	$39.87 - $69.36 $41,743 - $72,619	1,047 Added 3.46%	31,268 $2.17 Million
Q4 2018 Feb 13, 2019	SELL	$38.89 - $77.3 $69,029 - $137,207	-1,775 Reduced 5.55%	30,221 $1.31 Million
Q3 2018 Nov 13, 2018	SELL	$71.81 - $90.15 $27,646 - $34,707	-385 Reduced 1.19%	31,996 $2.44 Million
Q2 2018 Sep 27, 2018	BUY	$48.54 - $85.31 $547,191 - $961,699	11,273 Added 53.41%	32,381 $2.49 Million
Q2 2018 Aug 10, 2018	SELL	$48.54 - $85.31 $579,761 - $1.02 Million	-11,944 Reduced 36.14%	21,108 $483,000
Q1 2018 May 14, 2018	BUY	$44.33 - $58.52 $278,614 - $367,798	6,285 Added 23.48%	33,052 $1.69 Million
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $53,641 - $70,618	1,232 Added 4.82%	26,767 $1.24 Million
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $1.27 Million - $1.69 Million	25,535	25,535 $1.36 Million

325

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.22B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.